Table 5. ORR and by subgroups.
| Characteristic | Response rate | OR2 | 95% CI | P value |
|---|---|---|---|---|
| Treatment response | ||||
| SD | 86/140 (61%) | |||
| PD | 14/140 (10%) | |||
| PR | 40/140 (29%) | |||
| IMDC risk groups | 0.007 | |||
| Favorable | 20/46 (43%) | – | – | |
| Intermediate | 20/94 (21%) | 0.35 | 0.16–0.75 | |
| IMDC risk factors | 0.027 | |||
| 0 | 20/46 (43%) | – | – | |
| 1 | 12/57 (21%) | 0.35 | 0.14–0.81 | |
| 2 | 8/37 (22%) | 0.36 | 0.13–0.93 |
ORR, overall response rate; OR, odds ratio; SD, stable disease; PD, progressive disease; PR, partial response; IMDC, International Metastatic renal cell carcinoma Database Consortium; CI, confidence interval.